See ratings and reviews when you sign up for an account.

Vaccination of Patients With Advanced Melanoma, Pancreatic, Colon and Cervical Cancer With HLA-A1, -A2 and -B35 Restricted Survivin Peptides

This study is currently Recruiting

June 2005 By Julius-Maximilians University

First Recieved on April 19, 2005

Last Updated on July 27, 2006

Sponsor: Julius-Maximilians University
Information provided by: Julius-Maximilians University
Identifier: NCT00108875


This study evaluates the safety, the immunological response and the clinical outcome of a vaccination with survivin peptides for patients with advanced melanoma, pancreatic, colon and cervical carcinoma.

Study Type: Interventional
Study Design: Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment


Ages Eligible for Study:19 Years
Genders Eligible for Study:Both
Accepts Healthy Volunteers:No

Inclusion Criteria: - Advanced melanoma, pancreatic, colon and cervical cancer - At least 1 prior postoperative conventional therapy (chemotherapy, radiation, immunotherapy) - HLA-A1, -A2, -B35 - More than 4 weeks since last chemo-, immune- or radiotherapy - ECOG-PS (Eastern Cooperative Oncology Group- Performance Status) of 0-1 - Sufficient renal, hepatic and bone marrow function: thrombocytes > 75.000/ul; hb > 9 g/dl; leucocytes > 2.500/ul; creatinine < 2 mg/dl; GOT/GPT < twice the normal value - negative for HIV and Hbs - Older than 18 years - Informed consent Exclusion Criteria: - Acute/chronic infections - Positive for HIV, Hbs - Autoimmune disorders - Pregnancy, breast feeding


  • Investigator: Juergen C Becker, MD - Principal Investigator - Department of Dermatology, University of Wuerzburg, Germany


  • Julius-Maximilians-University of Wuerzburg, Germany, Department of Dermatology

    Wuerzburg, Bavaria 97080 Germany

Disclaimer: The list and ratings above are for informational purposes only, and is intended to supplement, not substitute for, the expertise and judgment of your physician, pharmacist or other healthcare professional. The goal of the information is to provide you with a comprehensive view of all available treatments, but should not be construed to indicate that use of any one treatment is safe, appropriate, or effective for you. Decisions about use of a new treatment, or about a change in your current treatment plan, should be in consultation with your doctor or other healthcare professional.